Literature DB >> 21394490

How well do we recognise non-motor symptoms in a British Parkinson's disease population?

Michele Hu1, Jonathan Cooper, Rebecca Beamish, Emma Jones, Richard Butterworth, Lesley Catterall, Yoav Ben-Shlomo.   

Abstract

Although awareness of non-motor symptoms in Parkinson's disease (PD) has recently increased, little is known about their recognition and treatment in routine clinical practice. We therefore applied non-motor rating scales for dementia, depression, anxiety and excessive daytime sleepiness to a community-ascertained cohort of 202 PD patients. Hospital case notes were reviewed for evidence that the non-motor problems had been recognized and whether any action had been taken to ameliorate or assess these symptoms. The prevalence of each non-motor problem was as follows: dementia 25.3% (95% CI 19.0, 32.4), depression 37.3% (95% CI 30.6, 44.4), anxiety 31.3% (95% CI 25.0, 38.2), excessive daytime sleepiness 59.4% (95% CI 52.2, 66.3). However, these features were only recognised in 27.2, 38.7, 9.5, and 12.8%, respectively. We did not identify any specific factor that predicted under-recognition. Our study shows that when rating scales are applied to formally assess for non-motor symptoms a large clinical 'iceberg effect' emerges with the majority of symptoms going unrecognised and untreated.

Entities:  

Mesh:

Year:  2011        PMID: 21394490     DOI: 10.1007/s00415-011-5972-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease.

Authors:  K R Chaudhuri; S Pal; A DiMarco; C Whately-Smith; K Bridgman; R Mathew; F R Pezzela; A Forbes; B Högl; C Trenkwalder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Anthony H V Schapira; Fabrizio Stocchi; Kapil Sethi; Per Odin; Richard G Brown; William Koller; Paolo Barone; Graeme MacPhee; Linda Kelly; Martin Rabey; Doug MacMahon; Sue Thomas; William Ondo; David Rye; Alison Forbes; Susanne Tluk; Vandana Dhawan; Annette Bowron; Adrian J Williams; Charles W Olanow
Journal:  Mov Disord       Date:  2006-07       Impact factor: 10.338

Review 3.  A systematic review of prevalence studies of dementia in Parkinson's disease.

Authors:  Dag Aarsland; Julia Zaccai; Carol Brayne
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

4.  Non-recognition of depression and other non-motor symptoms in Parkinson's disease.

Authors:  L M Shulman; R L Taback; A A Rabinstein; W J Weiner
Journal:  Parkinsonism Relat Disord       Date:  2002-01       Impact factor: 4.891

Review 5.  The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential.

Authors:  K Ray Chaudhuri; L Yates; P Martinez-Martin
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

Review 6.  Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.

Authors:  David J Burn
Journal:  Mov Disord       Date:  2002-05       Impact factor: 10.338

7.  Pilot study of a three-step diagnostic pathway for young and old patients with Parkinson's disease dementia: screen, test and then diagnose.

Authors:  Sarah H M Robben; Monique J M Sleegers; Paul L J Dautzenberg; Floor S van Bergen; Jan-Pieter ter Bruggen; Marcel G M Olde Rikkert
Journal:  Int J Geriatr Psychiatry       Date:  2010-03       Impact factor: 3.485

8.  Direct economic impact of Parkinson's disease: a research survey in the United Kingdom.

Authors:  Leslie Findley; Manjit Aujla; Peter G Bain; Mary Baker; Catherine Beech; Clive Bowman; Jeremy Holmes; Wendy K Kingdom; Douglas G MacMahon; Viv Peto; Jeremy R Playfer
Journal:  Mov Disord       Date:  2003-10       Impact factor: 10.338

9.  The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism.

Authors:  J C Pressley; E D Louis; M-X Tang; L Cote; P D Cohen; S Glied; R Mayeux
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

10.  The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening.

Authors:  Eneida Mioshi; Kate Dawson; Joanna Mitchell; Robert Arnold; John R Hodges
Journal:  Int J Geriatr Psychiatry       Date:  2006-11       Impact factor: 3.485

View more
  10 in total

1.  Concordance between severity of disease, prevalence of nonmotor symptoms, patient-reported quality of life and disability and use of medication in Parkinson's disease.

Authors:  Alberto Raggi; Matilde Leonardi; Venusia Covelli; Alberto Albanese; Paola Soliveri; Francesco Carella; Luigi Romito
Journal:  Neurol Sci       Date:  2011-11-10       Impact factor: 3.307

2.  Framing advance care planning in Parkinson disease: Patient and care partner perspectives.

Authors:  Hillary D Lum; Sarah R Jordan; Adreanne Brungardt; Roman Ayele; Maya Katz; Janis M Miyasaki; Anne Hall; Jacqueline Jones; Benzi Kluger
Journal:  Neurology       Date:  2019-04-26       Impact factor: 9.910

Review 3.  A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Authors:  Lama M Chahine; Amy W Amara; Aleksandar Videnovic
Journal:  Sleep Med Rev       Date:  2016-08-31       Impact factor: 11.609

4.  Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease.

Authors:  Danielle S Abraham; Thanh Phuong Pham Nguyen; Sean Hennessy; Shelly L Gray; Dawei Xie; Daniel Weintraub; Allison W Willis
Journal:  Am J Geriatr Psychiatry       Date:  2020-05-18       Impact factor: 4.105

5.  The effect of directional social cues on saccadic eye movements in Parkinson's disease.

Authors:  Koray Koçoğlu; Gülden Akdal; Berril Dönmez Çolakoğlu; Raif Çakmur; Jagdish C Sharma; Gemma Ezard; Frouke Hermens; Timothy L Hodgson
Journal:  Exp Brain Res       Date:  2021-04-29       Impact factor: 1.972

Review 6.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

7.  Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives.

Authors:  Fahd Baig; Michael Lawton; Michal Rolinski; Claudio Ruffmann; Kannan Nithi; Samuel G Evetts; Hugo R Fernandes; Yoav Ben-Shlomo; Michele T M Hu
Journal:  Mov Disord       Date:  2015-07-14       Impact factor: 10.338

8.  Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial.

Authors:  Matthew C L Phillips; Deborah K J Murtagh; Linda J Gilbertson; Fredrik J S Asztely; Christopher D P Lynch
Journal:  Mov Disord       Date:  2018-08-11       Impact factor: 10.338

9.  Symptom burden among individuals with Parkinson disease: A national survey.

Authors:  Christopher G Tarolli; Grace A Zimmerman; Peggy Auinger; Scott McIntosh; Robert K Horowitz; Benzi M Kluger; E Ray Dorsey; Robert G Holloway
Journal:  Neurol Clin Pract       Date:  2019-11-18

10.  Educational Needs and Considerations for a Visual Educational Tool to Discuss Parkinson's Disease.

Authors:  Sean J Udow; Douglas E Hobson; Galit Kleiner; Mario Masellis; Susan H Fox; Anthony E Lang; Connie Marras
Journal:  Mov Disord Clin Pract       Date:  2017-11-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.